H.I.G. HealthBridge Partners β Full Portfolio
27 tracked investments Β· listed companies and verified rows first
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.
BiotechDigital HealthHealthtechMedical DevicesVista, US
Thierry Dervieux(Executive Officer)inWendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)
BoardJames L.L. Tullis(Director)inBrian Birk(Director)Ebetuel Pallares(Director)
Co-investorsCottonwood Technology FundEPIC VENTURESH.I.G. CapitalSun Mountain CapitalTullis Health InvestorsTullis
RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)in
BoardJavier Perez-Sala(Director)Jan Bonel(Director)
Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalLongitude CapitalRA CapitalVisionary Ventures+1 more
Developing a novel treatment for acute muscle spasms.
BiotechSan Diego, US
Kathleen D. Scott(Chief Financial Officer, Secretary and Treasurer)Judy Caron(Chief Operating Officer)David F. Hale(Chairman of the Board of Directors, Acting President and CEO)Brian Dorsey(Director)Daniel Becker(Director)Joshua Richardson(Director)
Board seatAlex ZissonΒ· per SEC Form D Β· $3.8M raise Β· filed May 2018
Co-investorsSofinnova VenturesLongitude Capital
BiotechBothell, US
Randall Schatzman(Executive Officer, Director)Jeffrey Smith(Executive Officer)James Bucher(Executive Officer)Randal Hassler(Executive Officer)Elisabeth Sandoval(Executive Officer)
BoardHeather Preston(Director)
Co-investorsH.I.G. Capital
Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.
BiotechConsumerHealthtechZug, CH
Co-investorsAndera PartnersF-Prime CapitalH.I.G. Capital
Augmedics develops augmented reality surgical navigation technology aimed at improving outcomes in spine surgery.
HardwareHealthtechMedical DevicesArlington Heights, US
Nissan Elimelech(Chief Executive Officer)
Co-investorsAlmeda VenturesEvidity Health CapitalH.I.G. CapitalPartners ResoluteXR Invest
BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development.
Advanced ManufacturingBiotechHealthtech
Co-investorsH.I.G. Capital
Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients.
BiotechDigital HealthHealthtechMedical DevicesLincoln, US
Co-investorsH.I.G. CapitalSV Health Investors
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inDavid Klein(Executive Officer, Director)inRandall Stanicky(Executive Officer)in
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Co-investorsAccelmed PartnersH.I.G. CapitalHealth Catalyst CapitalHikma VenturesSanofi VenturesSupernode Ventures+2 more
HealthtechMenlo Park, US
Eugene de Juan, Jr., M.D.(Director)K. Angela Macfarlane(Executive Officer, Director)John F. Maroney(Executive Officer, Director)
BoardRobert C. Bellas, Jr.(Director)Hanson S. Gifford III(Executive Officer, Director)Jim Glasheen(Director)
Co-investorsH.I.G. CapitalLightstone VenturesVersant Ventures
Highridge Medical presents itself as a medical company built on a history of product innovation, led by an executive leadership team.
HardwareHealthtechMedical Devices
Co-investorsCorewell Health VenturesH.I.G. Capital
Develops innovative medical devices for ophthalmology, general, and specialty surgery markets.
Co-investorsH.I.G. Capital
BiotechHealthtechWayne, US
Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)
Co-investors415 CapitalH.I.G. CapitalRunway Growth CapitalH.I.G. BioHealth PartnersNew Enterprise Associates (NEA)Vensana Capital
Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.
BiotechHealthtechMedical DevicesDenver, US
Co-investorsCorewell Health VenturesEscalate Capital PartnersFrazier Healthcare PartnersH.I.G. CapitalKaiser Permanente VenturesRex Health Ventures+2 more
Navitas Life Sciences is a global clinical research partner providing clinical, regulatory, safety, and data management solutions to pharmaceutical, biotech, and federal agencies for drug development and patient safety.
BiotechData & InfrastructureDigital HealthHealthtechMedical Devices
Srinivasan H.R.(Chief Executive Officer)
Co-investorsH.I.G. Capital
Develops and commercializes energy-based soft tissue ablation devices for various clinical markets.
Co-investorsH.I.G. Capital
BiotechBridgewater, US
Navneet Puri(Executive Officer)
Co-investorsH.I.G. CapitalOxford Finance LLC
Develops and commercializes medical devices based on a proprietary imaging platform for diagnosis and treatment of diseases.
Co-investorsH.I.G. Capital
On Target Laboratories is a company of scientists and researchers focused on cancer surgery, developing products to support surgical oncology.
BiotechHealthtechMedical Devices
Bill Peters(President, Chief Executive Officer, and Board Member)Rod MacLeod(Chief Financial Officer)inTommy Lee(Senior Vice President of Clinical Operations)Catherine Brisson(Vice President of Regulatory Affairs and Quality)Anne Fornicola(Vice President of Chemistry, Manufacturing and Controls)Scott Huennekens(Executive Chairperson)
Co-investors3B Future Health FundCerity Partners VenturesElevate VenturesH.I.G. Capital
Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy.
BiotechHealthtechAptos, US
Jason Levin(Founder, Director and Chief Executive Officer)Robert M. Myers(Executive Officer, Director)
BoardMichael Wasserman(Director)Patrick Enright(Director)Elisha (Terry) Gould(Director)Ernest Mario(Director)
Co-investorsH.I.G. CapitalLongitude CapitalAgent Capital
Specialty pharmaceutical company built on patent-protected dermal delivery technologies.
Co-investorsH.I.G. Capital
Develops and markets generic and specialty branded pharmaceutical products, based in New Brunswick, NJ.
Co-investorsH.I.G. Capital
Develops oncology drugs for hematologic cancers; acquired by Cephalon Inc. in 2005.
Co-investorsH.I.G. Capital
Taconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services.
BiotechDeep TechHealthtech
Co-investorsH.I.G. Capital
HealthtechSan Clemente, US
Jeff Swiecki(Executive Officer)Earl R. Fender(Executive Officer, Director)Robert Reitzler(Executive Officer)Scott C. Lynch(Executive Officer)Jeffrey A. Swiecke(Executive Officer)Anthony G. Mauriello(Executive Officer)
Co-investorsH.I.G. CapitalAlta Partners
Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions.
Digital HealthHealthtechMedical Devices
Co-investors7wire VenturesCorewell Health VenturesH.I.G. CapitalSV Health InvestorsAccelGeneral Catalyst+3 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.